Global Infusion Pump Market Size study & Forecast, by Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and PCA Pumps), By Application (Diabetes, Oncology, Pain Management), By End User (Hospitals &

Global Infusion Pump Market Size study & Forecast, by Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and PCA Pumps), By Application (Diabetes, Oncology, Pain Management), By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings) and Regional Analysis, 2022-2029

Global Infusion Pump Market is valued at approximately USD 9.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.3% over the forecast period 2022-2029. A medical device is an infusion pump that is used to deliver several fluids to the body under controlled conditions. In hospitals, nursing homes, long-term care facilities, and home settings, the pump is used to provide intravenous medications. Infusion pumps are used in the treatment and management of diabetes, gastroenterology, haematology, neonatology, analgesia, and chemotherapy. The key factor driving the market growth is the rising incidence of chronic diseases along with rapid growth in the geriatric population, increasing number of surgical procedures, and growing demand for ambulatory infusion pumps in home care settings. Thus, propelling the lucrative demand for the market during the forecast period.

Infusion pumps provide key benefits over manual delivery of fluids such as the ability to deliver the fluids in a very small dosage and at accurate predefined rates. These pumps are often used to deliver medication to maintain drug levels in the bloodstream stable in cases such as cancer and diabetes. According to the Centers for Disease Control and Prevention (CDC), there were34.2 million adult diabetics in the United States or 10.5% of the population, and there was around 463 million cases of diabetes globally in 2020. Insulin pumps are becoming more and more popular for managing type 1 diabetes. To enable continuous drug delivery for these patients, user-friendly self-controlled pumps are required. This factor is driving the market expansion for infusion pumps throughout every region. Also, the rising adoption of specialty infusion systems would create lucrative opportunities for the market during the forecast period. However, the stringent regulations to produce pumps stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Infusion Pump Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the higher diagnosis and treatment rates for diabetes and favourable reimbursement policies in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as rising incidence of health-related problems such as heart disease, obesity, diabetes, and other chronic diseases and growing investment by the key market players would create lucrative growth prospects for the Infusion Pump market across Asia Pacific region.

Major market player included in this report are:
Medtronic (Ireland)
Becton Dickinson and Company (U.S.)
Baxter (U.S.)
Insulet Corporation (U.S.)
ICU Medical, Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Smiths Medical (Smiths Group plc.) (U.S.)
Fresenius Kabi AG (Germany)
Terumo Corporation (Japan)
F. Hoffmann-La Roche Ltd (Switzerland)
Recent Developments in the Market:
 In Apr 2021, Medtronic has announced the launch of the world’s first and only infusion set which can be used for up to 7 days in select European countries. This set is responsible for providing insulin from the pump into the human body. All MiniMed insulin pumps from the 600 and 700 series are compatible with this new set.


Global Infusion Pump Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Application, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:

By Type:
Volumetric Pumps
Syringe Pumps
Enteral Pumps
Insulin Pumps
Elastomeric Pumps
Implantable Pumps
PCA Pumps
By Application:
Diabetes
Oncology
Pain Management
By End User:
Hospitals & Clinics
Ambulatory Care Settings
Home Care Settings

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Medtronic (Ireland)
Becton Dickinson and Company (U.S.)
Baxter (U.S.)
Insulet Corporation (U.S.)
ICU Medical, Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Smiths Medical (Smiths Group plc.) (U.S.)
Fresenius Kabi AG (Germany)
Terumo Corporation (Japan)
F. Hoffmann-La Roche Ltd (Switzerland)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.